|
Amgen Inc |
|
United States |
+1 (805) 447-1000 |
Acquisition |
|
|
|
Avalon Ventures |
|
United States |
+1 (858) 348-2180 |
N/A |
|
|
|
Avalon Ventures |
|
United States |
+1 (858) 348-2180 |
Series E |
|
|
|
Beringea LLC |
Transatlantic venture capital firm. |
United States |
+1 (248) 489-9000 |
N/A |
|
|
|
Crédit Agricole Private Equity |
|
France |
|
Series F |
|
|
|
Crédit Agricole Private Equity |
|
France |
|
Series E |
|
|
|
Excalibur Fund Managers Ltd |
|
United Kingdom |
+44 (20) 7887-7642 |
N/A |
|
|
|
Forbion Capital Partners |
|
Netherlands |
+31 (35) 699-3000 |
Series F |
|
|
|
Forbion Capital Partners |
|
Netherlands |
+31 (35) 699-3000 |
Series E |
|
|
|
GeneChem Management Inc |
Venture capital firm targeting companies in the genomics industry |
Canada |
+1 (514) 849-7696 |
Series E |
|
|
|
GeneChem Management Inc |
Venture capital firm targeting companies in the genomics industry |
Canada |
+1 (514) 849-7696 |
N/A |
|
|
|
Harris & Harris Group Inc (HHVC) |
Internally managed venture capital company specializing in nanotechnology and microsystems |
United States |
+1 (212) 582-0900 |
Series F |
|
|
|
Innoven Partenaires SA |
|
France |
+33 (1) 4703-1818 |
Series F |
|
|
|
Innoven Partenaires SA |
|
France |
+33 (1) 4703-1818 |
Series E |
|
|
|
Lloyds TSB Development Capital Ltd (LDC) |
The private equity arm of Lloyds Banking Group. |
United Kingdom |
+44 (117) 360-1970 |
N/A |
|
|
|
Morningside Group |
|
China |
+852 2894-9800 |
N/A |
|
|
|
MVM Life Science Partners LLP |
Venture capital firm which invests in technologies and products for the life science and healthcare markets |
United Kingdom |
+44 (20) 7557-7500 |
N/A |
|
|
|
New Science Ventures (NSV) |
Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs. |
United States |
|
Series F |
|
|
|
New Science Ventures (NSV) |
Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs. |
United States |
|
Series E |
|
|
|
Omega Fund Management UK LLP |
|
United Kingdom |
|
N/A |
|
|
|
Scottish Equity Partners LLP (SEP) |
|
United Kingdom |
+44 (141) 273-4000 |
Series F |
|
|
|
Scottish Equity Partners LLP (SEP) |
|
United Kingdom |
+44 (141) 273-4000 |
Series E |
|
|
|
Sectoral Asset Management Inc |
|
Canada |
|
N/A |
|
|
|
Triathlon Medical Ventures LLC |
|
United States |
|
Series F |
|
|
|
Triathlon Medical Ventures LLC |
|
United States |
|
Series E |
|
|
|
Ventech SA |
|
France |
|
N/A |
|
|
|
Ysios Capital Partners SGECR SA |
Spanish venture capital firm focused on the healthcare space. |
Spain |
+34 (93) 403-9772 |
N/A |
|
|